Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Cash (2018 - 2025)

Historic Change in Cash for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $30.4 million.

  • X4 Pharmaceuticals' Change in Cash rose 16107.52% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.8 million, marking a year-over-year increase of 1929.72%. This contributed to the annual value of -$43.8 million for FY2024, which is 9215.54% down from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Change in Cash stood at $30.4 million, which was up 16107.52% from -$1.0 million recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Change in Cash high stood at $86.7 million for Q2 2024, and its period low was -$49.8 million during Q3 2024.
  • Its 5-year average for Change in Cash is -$540368.4, with a median of -$15.4 million in 2022.
  • Per our database at Business Quant, X4 Pharmaceuticals' Change in Cash soared by 67728.29% in 2022 and then plummeted by 92629.84% in 2024.
  • Over the past 5 years, X4 Pharmaceuticals' Change in Cash (Quarter) stood at $5.4 million in 2021, then skyrocketed by 677.28% to $41.9 million in 2022, then plummeted by 177.26% to -$32.4 million in 2023, then decreased by 28.96% to -$41.7 million in 2024, then soared by 172.89% to $30.4 million in 2025.
  • Its last three reported values are $30.4 million in Q3 2025, -$1.0 million for Q2 2025, and -$15.4 million during Q1 2025.